Ann: Commercial-scale GMP medicinal cannabis resin extraction, page-43

This is very substantial announcement indeed..
Can $2 with not product and now has product should edge back to that mark..
i will say I am surprised by the lack of interest in our partners who have the licenses in Australia and abroad to manufacture and package these medicinal high potency products
Both party’s benefit significantly here
CAN & IDT are very well positioned for growth from this deal

IDT’s solvent extraction facilities and capabilities have been successfully utilised in respect of cannabis cultivars.

This represents the first commercial-scale resin extraction from Australian grown cultivars

The extracted resin will be formulated into a full range of GMP medicinal cannabis finished dosage form products, including formulations featuring high THC, high CBD and balanced formulations. These products will be formulated and packed by IDT and made available via the Special Access Scheme (SAS) to Australian prescribers and patients, and will be positioned for export to markets overseas